[A case of six metachronous primary malignancies]

Area of Science:

• Oncology
• Clinical Case Study
• Cancer Survivorship

Background:

• Advances in cancer detection and therapy have increased patient survival, leading to a rise in multiple primary malignancies.
• Managing patients with numerous co-existing or sequential cancers requires careful consideration of prior treatments and disease characteristics.

Observation:

• A 55-year-old male presented with six distinct primary malignancies over 14 years: malignant lymphoma, gastric cancer, ureteral cancer, small cell lung cancer, bladder cancer, and squamous cell lung cancer.
• Synchronous ureteral and small cell lung cancers complicated treatment sequencing, necessitating delays in chemotherapy initiation.
• Prior chemotherapy for malignant lymphoma and subsequent neutropenia-induced infection restricted treatment options for subsequent cancers.

Findings:

• Treatment for small cell lung cancer was delayed and dose intensity reduced due to myelosuppression from prior lymphoma chemotherapy.
• A postoperative abdominal infection led to chemotherapy discontinuation for small cell lung cancer, requiring radiotherapy.
• Therapies for the sixth malignancy, squamous cell lung cancer, were further limited by compromised lung function and myelopoiesis.

Implications:

• The management of multiple primary malignancies necessitates a personalized approach, considering the interplay of different cancers and the cumulative effects of therapies.
• Treatment strategies must balance the need for aggressive cancer control with the risk of treatment-related morbidities and functional decline.
• This case underscores the importance of multidisciplinary care and careful monitoring in long-term cancer survivors with multiple diagnoses.